Comparison of immediate results and follow-up of patients with single-vessel and multivessel coronary artery disease younger than 50 years of age undergoing coronary stent implantation.

Autor: Anello AL; Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., Moscoso I, Tófano RJ, Salman AA, Cristóvão SA, Mauro MF, Batista de O Neto J, Mangione JA
Jazyk: English; Portuguese
Zdroj: Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2003 Nov; Vol. 81 (5), pp. 494-505. Date of Electronic Publication: 2003 Dec 01.
DOI: 10.1590/s0066-782x2003001300006
Abstrakt: Objective: To assess the in-hospital results and clinical follow-up of young patients (< 50 years) with multivessel coronary artery disease undergoing stent implantation in native coronary arteries and to compare their results with those of patients with single-vessel coronary artery disease.
Methods: We retrospectively studied 462 patients undergoing coronary stent implantation. Patients were divided into 2 groups: group I (G-I) - 388 (84%) patients with single-vessel coronary artery disease; and group II (G-II) - 74 (16%) patients with multivessel coronary artery disease.
Results: The mean age of the patients was 45 4.9 years, and the clinical findings at presentation and demographic data were similar in both groups. The rate of clinical success was 95% in G-I and 95.8% in G-II (P=0.96), with no difference in regard to in-hospital evolution between the groups. Death, acute myocardial infarction, and the need for myocardial revascularization during clinical follow-up occurred in 10.1% and 11.2% (P=0.92) in G-I and G-II, respectively. By the end of 24 months, the actuarial analysis showed an event-free survival of 84.6 % in G-I and 81.1% in G-II (P=0.57).
Conclusion: Percutaneous treatment with coronary stent implantation in young patients with multivessel disease may be safe with a high rate of clinical success, a low incidence of in-hospital complications, and a favorable evolution in clinical follow-up.
Databáze: MEDLINE
Externí odkaz: